We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research for Latin America.
We provide our CRO Services with offices in:
Chile (to be opened Q4 2017)
Peru (to be opened Q4 2017)
Cohortias is a joint venture between Julius Clinical and Zumanis. We have a proven track record conducting several large studies over the past 7 years.
Julius Clinical is the leading European Science CRO, based in the Netherlands. It focuses on high impact clinical trials for Phases II, III and IV, with the unique approach of combining strong scientific leadership and operational excellence to conduct innovative global clinical trials.
Julius Clinical involves a staff of internationally recognized academic leaders in the design, conduct, and interpretation of clinical trials, combined with personal links and peers around the world, for a truly global reach and reputation. The company uses its scientific expertise to communicate trial results widely and independently, through papers in leading journals.
Julius Clinical was established as a spin-off from the University Medical Center of Utrecht University, in the Netherlands.
Zumanis is an Innovation for Healthcare group, with a clear determination to enrich the offering, increase access and improve quality for each and every individual. It is focused on the most common health conditions and health-system problems in Latin America, looking to build a stronger and more synergic health system, while standing for the patient’s good above all.
Zumanis is working to reinvent business models, and also clinical and administrative processes by using information, science and technology to design disruptive and high value solutions for health.
Zumanis is based in Monterrey, Mexico, and has 3 business verticals (each with subsidiaries), including retail healthcare, digital healthcare and clinical research. By combining these operations, new and interesting synergies are being explored.
Clinical Development Services
Clinical Operations Services
- Site selection (including feasibility)
- Site Management
- Clinical Monitoring (including risk based monitoring)
Regulatory support in each country
Phase II and III
We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards.
The current landscape of clinical research is bringing CLINICAL DEVELOPMENT and COMMERCIALIZATION together.
We offer services in the following Therapeutic Areas
- Infectious diseases
to your business
Academic leadership and a broad network of sites in several therapeutic areas
- Peer-to-peer management of our sites ensure high recruitment and retention.
High speed Execution
- We offer the quickest start-up times in each country
- Site selection
- Site contracting
- Above average performance standards (metrics)
- Top tier query resolution
Business acuity and flexibility
- Ad-hoc administrative support
- Offering innovative pricing models
- Short lines of communication
- Capacity for fast adaptation
We operate in a people’s business where personal contact and good communication make a huge difference. From finding sites, helping in the recruitment process or resolving queries, they exploit such interpersonal skills as the basis for our success. We are very proud to present our team.
President of the Board
Strategist & entrepreneur from Monterrey, with a professional carrier in health management. He was Dean of the Health Sciences Division for Tec de Monterrey, where he started the first ARO operation. He also launched the Innovation & Entrepreneurship Division in Biotechnology & Health. Later, he became Secretary of the Board for TecSalud, the Healthcare branch of Tec de Monterrey.
He is the lead advisor in health for the Nuevo Leon Council for Strategic Planning & Development. A non-governmental organization supported by Montrrey's main business leaders seeking to enforce a long-term vision for critical state-wide issues.
Jose is an MD from Tec de Monterrey, and holds an MBA by EGADE and a Masters in Research Methodology by IE Business School.
Aize has over 25 years of clinical development experience, including pharma, biotech and medical devices. His experience includes a wealth of clinical development projects executed around the globe.
With a long successful track record in the CRO sector, Aize recently worked for Chiltern as member of the executive board. As COO of Chiltern, he was responsible for Global Operations and helped transform the business to a global organization for clinical development.
Aize joined Julius Clinical in December 2015. He values true cooperation and a partnership approach with our client base as well as with academic partners and site networks to achieve real innovative results. Aize has a degree in Biochemistry from the University of Groningen, the Netherlands.
Rick Grobbee has been a principal investigator in many large-scale epidemiologic studies and randomized intervention trials relating to the prevention and treatment of cardiovascular disease. His experience covers the full range of study designs including trials, cohorts and case-control studies. In addition, he has worked on theoretical principles and methods of diagnostic and prognostic research.
He is the Chief Scientific Officer at Julius Clinical, and a Professor of Clinical Epidemiology at the University Medical Center (UMC) Utrecht, the Netherlands. His other current roles include chair of the focus area Circulatory Health at the UMCU.
Rick Grobbee supervises a comprehensive international MSc course on epidemiology, and runs satellite courses in various Central European Countries, Africa, Japan, Malaysia, and Indonesia. He has previously chaired the Netherlands Consensus Conference on Diagnosis and Treatment of Hypertension, was a past president of the Netherlands Society of Epidemiology, and is a member of the Dutch Consensus Committee for Cardiovascular Prevention.
Financial & business executive from Monterrey, with a family tradition of working in the health industry. He was administrative director of Industrial Benavides, once the largest manufacturer and provider of antibiotics for the public sector in Mexico. Benavides also became the largest drugstore chain in Mexico.
He is currently Board Member of The Life Raft Group, a world-wide patient advocate organization for Gastro-Intestinal Stromal Tumor (GIST). He is president of GIST for Latin-America, promoting awareness, access and clinical research for this type of cancer. He is also a member of the Novartis advisory board for GIST.
Rodrigo is a Certified Public Accountant and holds an MBA from Tec de Monterrey.
Chief Executive Officer
Martijn has over 20 years’ experience ranging from General Management to Director Level within several different industries. The past 7 years he has developed himself within the CRO and pharmaceutical industry by managing some large international Phase III studies through the international network of partners at Julius Clinical.
Since April 2017 Martijn was appointed as CEO of Cohortias, next to his work at Julius Clinical. The main objective is to build a leading Science CRO within Latin America and increase the number of trials in Latin America since Martijn strongly believes in opening the opportunity of Clinical trials for the patient population in Latin America, and thus leveraging the transformation of healthcare in the region, through better access for care and better care for each one.
Martijn is highly driven by teamwork and an entrepreneurial environment giving both responsibility and freedom to his teams in order to achieve our common goals.
Chief Scientific Officer
Renowned physician & academic from Monterrey. He was Academic Vice-President for TecSalud, and also Dean of the School of Biotechnology & Health. He has also been Vice-president for International Relations & Development for TecSalud.
He is a Board Member of the Association of Academic Health Centers, and Board Member of Universitas 21, the leading global network of research universities for the 21st century. He is also currently Board Member at Clinica Nova, and an active member of the National Researchers System (SNI) in Mexico.
Martin is a Pneumologist & Critical Care Specialist from Baylor College of Medicine, where he received the Henry D. McIntosh award as chief resident. He holds a Masters Degree in Public Health from UT.
Advisor to the Board
Dr. Alcides Cupido has more than 30 years of experience within the drug development and Pharma industry. He joined Quintiles in 1995, opening the first office of Quintiles in Latin America. He was responsible of building the Quintiles presence in Latin America and the expansion to the whole region. He is currently Head of Clinical Development Services for the region.
Prior to joining Quintiles and after several years working in Intensive Care of a Pediatric Unit at the Children’s Hospital, he worked in Searle Monsanto as a Deputy Director and Pharmacovigilance Head and in Hoechst AG in Latin America as Head of Clinical Research for the Latin America South Cone. His experience includes strong knowledge of Clinical research as well as business administration. He has extensive regional experience in Finance, business administration and human resources.
Alcides has a degree of Medical Doctor from the University of Buenos Aires (summa cum laude) and a Professional Certificate in Marketing from the Chartered Institute of Marketing in Maidenhead, UK. Dr. Cupido is a well regard international speaker and has several publications and presentations.
Owen L. Bryan
Owen L. Bryan
Owen has wide experience in different research areas, such as basic research, patent registration and clinical research. From 2010 to date, he has worked as CRA, Lead CRA, Director of the Research Team and Quality Manager for different phase III clinical studies, mainly in Cardiology. Previously, he worked as a Clinical Chemist, Laboratorist, Industrial Property Specialist and participated in a project for the establishment of a vaccine production center.
In 2010 he joined the basic research team of Tecnologico de Monterrey. Months later, he began to work as a Clinical Research Associate at the same institution. To date. He is currently Quality Manager at Cohortias Mexico and teaches at the University of Monterrey. He has 6 publications among original and review articles, and is a member of the National System of Researchers of Mexico.
Owen graduated with a Bachelor in Clinical Chemistry and Biology from the University of Montemorelos, and holds a Master's Degree in Science in Molecular Biology and Genetic Engineering from the Universidad Autonoma de Nuevo Leon.
He obtained his PhD’s degree in 2015 in Sciences with a specialty in Molecular Biology and Genetic Engineering.
Erika is a professional whose great attention to detail and organization capacity have allowed her to stand out in the Regulatory Affairs area in projects she has participated in.
She has worked in international studies and in national studies, as part of the Pharmaceutical Industry (CROs) and with Educational Institutions (AROs), in therapeutic areas such as Cardiology and Oncology. Since January 2017 she has been the Manager of Regulatory Affairs at Cohortias México.
Erika holds a Nursing degree from the Universidad Autónoma de Nuevo León. She has 10 years of experience in the field of Clinical Research. During these years, she has held various positions such as Clinical Research Associate, Project Manager and Regulatory Affairs Specialist.
Clinical Trial Leader
Gabriela is convinced that Clinical Research is an interesting area, full of day-to-day challenges for those who are involved in it. She is very committed to doing Clinical Research under the highest National and International quality standards for the health of patients. In 2010 she started as Clinical Research Associate, working for Glaxosmith Kline on 2 Phase III vaccine projects simultaneously.
In 2011, she joined the Tecnologico de Monterrey's Academic Research Organization as Clinical Monitor, where for 5 years she held different positions and responsibilities in the area of Clinical Operations, such as Lead CRA, Project Manager and Clinical Team Lead for Latin America. Currently and since January of 2017 she is the Clinical Team Lead for Mexico, Argentina and Colombia in Cohortias Mexico.
Gabriela graduated with a Bachelor in Science in Chemical Engineering at the Universidad Autonoma de Nuevo Leon in December 2005 with honors. She began his experience in Clinical Research in 2006 as a Study Coordinator for clinical trials phase II and III, coordinating for 4 years in different therapeutic areas.
Clinical Research Associate
Evelyn is a professional whose love for research make her fully committed to her work. Thanks to her capacity of adaptation and organization she has become a key member in problem resolution, always complying with the pertinent regulations and establishments.
Since 2005, she has worked on various research protocols in different therapeutic areas, such as Cardiology, Oncology, Neurology, among others. She started in Clinical Research as a Study Coordinator and, later, as a Clinical Research Associate, which is her current position in Cohortias Mexico. She has participated, to date, in about 20 clinical trials carried out in Mexico.
Evelyn has a Bachelor in Chemistry, Bacteriology and Parasitology from the Faculty of Biological Sciences of the Universidad Autonoma de Nuevo León and is a certified Clinical Laboratorist Technician.
Clinical Research Associate
Rocio is a dynamic person, whose sense of responsibility and adaptation have made her an outstanding member of the organization Cohortias Mexico as a Clinical Monitor. Her first work experience was as Chemist for Farmacias Benavides, a renowned company in the health industry in Mexico.
She started working in Clinical Research in April 2008 as Pharmacist in a Study Site and, later, as a Study Coordinator for 2 years. She has been working since in trials in different therapeutic areas such as Cardiology, Metabolism, Endocrinology, among others. Since January 2010 to date, she has been working as a Clinical Research Associate.
Rocio graduated in 2005 from Universidad Autónoma de Coahuila with a Bachelor in Science in Chemistry and Pharmacobiology with an accentuation in Industrial Pharmacy.
Juan C. Villareal
Clinical Research Associate
Juan C. Villareal
Juan Carlos has been interested in health and well-being of people his whole life. His patience and commitment to improving life quality of Mexicans have led him to work in clinical research. That is why today he works as a Clinical Research Associate in Cohortias Mexico, a position that he considers to be an enriching experience and an important step in his professional career.
His previous experience includes Administrative Coordinator for the Academic Research Organization of Tecnológico de Monterrey. Since 2011, he started in Clinical Research working as a Clinical Trial Assistant, and later as a Clinical Research Associate for trials in Cardiology.
He completed his studies at Universidad Tec Milenio with a Bachelor in Science in Industrial Engineering, graduating in 2009. Upon obtaining his degree he strengthened his professional training with a Master’s degree in Business Administration in Quality and Productivity, by the same institution.
Clinical Trial Assistant
Evangelina is a talented young woman whose enthusiasm, dynamism and ease of communication have been factors for the optimal development of her position as Clinical Trail Assistant in Cohortias Mexico.
In 2015 she started working in clinical research as a Clinical Trial Assistant in the Academic Research Organization in Tecnologico de Monterrey. To date she has two years working in Clinical Resarch as a Clinical Trial Assistant in Clinical Trials Phase III in Cardiology.
Evangelina graduated with a Bachelor in Science in Biotechnology Engineering from Instituto Tecnológico y de Estudios Superiores de Monterrey in 2015. As an undergraduate student, she became familiarized with research in health sciences as an intern in basic research in projects of development of biopharmaceuticals from mammal cells. Is fluent in Spanish and English, has advanced knowledge of French and basic knowledge of Portuguese.
in Latin America
by combining our academic roots with our experience, and a large base of patients through an extensive network of sites and a strong commitment to deliver high quality data.